Newsroom

[NCHC] AEI Session on Financing Cures: White Hat or White Wash?

On Friday, July 11, AEI is hosting a session entitled “How will we pay for the cost of cures?” On its face this seems like a […]

Read more

[The Health Care Blog] The Coming Debate Over Specialty Drugs

The debate over the price of specialty drugs is intensifying and could well be the next major healthcare issue to dominate the national, even international, agenda. […]

Read more

[NCHC] New York Joins List of States Outraged Over Sovaldi

Costs to New Yorkers for One Drug Is 4 Times Entire Higher Education Spending A recent article in Capital New York  highlights the dilemma posed by […]

Read more

[Forbes.com] Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi?

Sovaldi, the new drug to treat and cure Hepatitis C has certainly caused quite an uproar in the US since its FDA approval in December of […]

Read more